REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
FITC-conjugated anti-human CD3 antibody | Biolegend | Cat# 300440; RRID: AB_2562046 |
BV510-conjugated anti-human CD3 antibody | Biolegend | Cat# 317331; RRID: AB_2561376 |
APC-Cy7-conjugated anti-human CD8 antibody | Biolegend | Cat# 301016; RRID: AB_314134 |
PerCP-Cy5.5-conjugated anti-human CD14 antibody | Biolegend | Cat# 325622; RRID: AB_893250 |
PerCP-Cy5.5-conjugated anti-human CD19 antibody | Biolegend | Cat# 302230; RRID: AB_2073119 |
PE-Cy7-conjugated anti-human CD25 antibody | Biolegend | Cat# 356107; RRID: AB_2561974 |
APC-conjugated anti-human CD137 antibody | Biolegend | Cat# 309809; RRID: AB_830671 |
BV421-conjugated anti-human CD107a antibody | Biolegend | Cat# 328625; RRID: AB_10899581 |
PE-conjugated anti-human IFN-γ antibody | BD Biosciences | Cat# 554552; RRID: AB_395474 |
PE-Cy7-conjugated anti-human TNF-α antibody | Biolegend | Cat# 502930; RRID: AB_2204079 |
APC-conjugated anti-human IL-2 antibody | Biolegend | Cat# 500310; RRID: AB_315097 |
Anti-ACE2 antibody | R&D Systems | Cat# AF933; RRID: AB_355722 |
APC-conjugated anti-goat IgG | R&D Systems | Cat# F0108; RRID: AB_573124 |
Goat normal IgG | R&D Systems | Cat# AB-108-C; RRID: AB_354267 |
Anti-SARS-CoV-2 S antibody | GeneTex | Cat# GTX635654; RRID: AB_2888548 |
APC-conjugated anti-rabbit IgG | Jackson ImmunoResearch | Cat# 111-136-144; RRID: AB_2337987 |
Rabbit normal IgG | SouthernBiotech | Cat# 0111-01; RRID: AB_2732899 |
Bacterial and virus strains | ||
SARS-CoV-2 (strain WK-521) | Matsuyama et al., 2020 | GISAID ID: EPI_ISL_408667 |
Biological samples | ||
Human PBMCs | This study | N/A |
Chemicals, peptides, and recombinant proteins | ||
Ficoll-Paque Plus | GE Healthcare Life Sciences | Cat# 17-1440-03 |
RPMI1640 medium | Thermo Fisher Scientific | Cat# 11875101 |
Fetal calf serum (FCS) | Sigma-Aldrich | Cat# 172012-500ML |
Penicillin streptomycin (PS) | Sigma-Aldrich | Cat# P4333-100ML |
Dulbecco’s modified Eagle’s medium (high glucose) | Wako | Cat# 044-29765 |
Eagle’s minimum essential medium (with L-glutamine and phenol red) | Wako | Cat# 051-07615 |
Dulbecco’s modified Eagle’s medium (low glucose) | Wako | Cat# 041-29775 |
G418 | Nacalai Tesque | Cat# G8168-10ML |
Dulbecco’s modified Eagle’s medium (high glucose) | Sigma-Aldrich | Cat# R8758-500ML |
Blasticidin | InvivoGen | Cat# ant-bl-1 |
Ham’s F-12K medium | Wako | Cat# 080-08565 |
Expi293 expression medium | Thermo Fisher Scientific | Cat# A1435101 |
SARS-CoV-2 PepTivator peptide pools | Miltenyi Biotec | Cat# 130-126-700 |
Recombinant human IL-2 | Peprotec | Cat# 200-02 |
NF9 peptide (NYNYLYRLF, residues 448-456 of the SARS-CoV-2 S protein) | This study | N/A |
L452R peptide (NYNYRYRLF, L5R in NF9) | This study | N/A |
Y453F peptide (NYNYLFRLF, Y6F in NF9) | This study | N/A |
7-aminoactinomycin D | Biolegend | Cat# 420404 |
Paraformaldehyde | Nacalai Tesque | Cat# 09154-85 |
Brefeldin A | Sigma-Aldrich | Cat# B7651 |
Monensin | Biolegend | Cat# 420701 |
PrimeSTAR GXL DNA polymerase | Takara | Cat# R050A |
KpnI | New England Biolab | Cat# R0142S |
NotI | New England Biolab | Cat# R1089S |
MluI-HF | New England Biolab | Cat# R3198L |
SmaI | New England Biolab | Cat# R0141L |
HpaI | New England Biolab | Cat# R0105L |
XhoI | New England Biolab | Cat# R0146S |
Bilirubin | Sigma-Aldrich | Cat# 14370-1G |
CF640R succinimidyl ester | Biotium | Cat# 92108 |
Lipofectamine 3000 | Thermo Fisher Scientific | Cat# L3000015 |
Lipofectamine 2000 | Thermo Fisher Scientific | Cat# 11668019 |
DNase I | Sigma-Aldrich | Cat# 11284932001 |
TransIT-LT1 | Takara | Cat# MIR2300 |
Puromycin | InvivoGen | Cat# ant-pr-1 |
Doxycycline | Takara | Cat# 1311N |
TURBO DNase | Thermo Fisher Scientific | Cat# AM2238 |
Minimum essential medium (2 × ), no phenol red | Thermo Fisher Scientific | Cat# 11935046 |
Nonessential amino acid | Thermo Fisher Scientifc | Cat# 11140-050 |
Carboxymethyl cellulose | Sigma-Aldrich | Cat# C9481-500G |
Formaldehyde | Nacalai Tesque | Cat# 37152-51 |
Crystal violet | Nacalai Tesque | Cat# 09804-52 |
Methylene blue | Nacalai Tesque | Cat# 22412-14 |
Recombinant RNase inhibitor | Takara | Cat# 2313B |
Transcriptor reverse transcriptase | Roche | Cat# 03531317001 |
Critical commercial assays | ||
Cytofix/Cytoperm Fixation/Permeabilization solution kit | BD Biosciences | Cat# 554714 |
QIAamp RNA blood mini kit | QIAGEN | Cat# 52304 |
SuperScript III reverse transcriptase | Thermo Fisher Scientific | Cat# 18080085 |
ExpiFectamine 293 transfection kit | Thermo Fisher Scientific | Cat# A14525 |
KAPA HiFi HotStart ReadyMix kit | Roche | Cat# KK2601 |
One-Glo luciferase assay system | Promega | Cat# E6130 |
GENEART site-directed mutagenesis system | Thermo Fisher Scientific | Cat# A13312 |
QIAamp viral RNA mini kit | QIAGEN | Cat# 52906 |
One Step TB Green PrimeScript PLUS RT-PCR kit | Takara | Cat# RR096A |
SARS-CoV-2 direct detection RT-qPCR kit | Takara | Cat# RC300A |
GeneJET gel extraction kit | Thermo Fisher Scientific | Cat# K0692 |
EnduRen live cell substrate | Promega | Cat# E6481 |
Experimental models: Cell lines | ||
Human: C1R-A2402 cells | Karaki et al., 1993 | N/A |
Human: HEK293 cells | ATCC | CRL-1573 |
Human: HEK293T cells | ATCC | CRL-3216 |
African green monkey (Chlorocebus sabaeus): Vero cells | JCRB | JCRB0111 |
African green monkey (Chlorocebus sabaeus): VeroE6/TMPRSS2 cells | JCRB | JCRB1819 |
Mink (Neovison vison): Mv.1.Lu cells | ATCC | CCL-64 |
Human: HEK293-C34 cells | Torii et al., 2021 | N/A |
Human: HEK293-ACE2 cells | This study | N/A |
Human: A549-ACE2 cells | This study | N/A |
Human: Expi293F cells | Thermo Fisher Scientific | Cat# A14527 |
Yeast (Saccharomyces cerevisiae): strain EBY100 | ATCC | MYA-4941 |
Oligonucleotides | ||
Forward primer for pC-SARS2-S: TTG GGTACC ATG TTT GTG TTC CTG GTG CTG | Ozono et al., 2021 | N/A |
Reverse primer for pC-SARS2-S: GTG GCGGCCGC TCT AGA TTC AGG TGT AGT GCA GTT T | Ozono et al., 2021 | N/A |
Forward primer for S L452R: GTG GGA GGC AAC TAC AAC TAC CGT TAC | This study | N/A |
Forward primer for S Y453F: GTG GGA GGC AAC TAC AAC TAC CTC TTC AGA | This study | N/A |
Reverse primer for S L452R/L453F: GTT GTA GTT GCC TCC CAC CTT | This study | N/A |
Forward primer for S N501Y: TCC TAT GGC TTC CAA CCA ACC TAT GGA | This study | N/A |
Reverse primer for S N501Y: TGG TTG GAA GCC ATA GGA TTG | This study | N/A |
Forward primer for S S13I: TGC CAC TGG TGT CCA TCC AGT GTG TGA ACC T | This study | N/A |
Reverse primer for S S13I: AGG TTC ACA CAC TGG ATG GAC ACC AGT GGC A | This study | N/A |
Forward primer for S W152C: GAA CAA CAA GTC CTG TAT GGA GTC TGA GTT C | This study | N/A |
Reverse primer for S W152C: GAA CTC AGA CTC CAT ACA GGA CTT GTT GTT C | This study | N/A |
Forward primer for S D614G: CTG TGC TCT ACC AGG GTG TGA ACT GTA CTG A | This study | N/A |
Reverse primer for S D614G: TCA GTA CAG TTC ACA CCC TGG TAG AGC ACA G | This study | N/A |
Forward primer for S HV69-70del: GGT TCC ATG CCA TCT CTG GCA CCA ATG GCA | This study | N/A |
Reverse primer for S HV69-70del: TGC CAT TGG TGC CAG AGA TGG CAT GGA ACC | This study | N/A |
Mink ACE2 forward primer for cloning: ATG TTA GGC TCT TCC TGG CTC CTT | This study | N/A |
Mink ACE2 reverse primer for cloning: CTA AAA TGA CGT CTG AAC ATC ATC GAC | This study | N/A |
Mink ACE2 forward primer for the preparation of mink ACE2 expression: TTG GGT ACC ATG TTA GGC TCT TCC TGG CTC C | This study | N/A |
Mink ACE2 reverse primer for the preparation of mink ACE2 expression: AAA GAT CTC GAG CTA AAA TGA CGT CTG AAC ATC | This study | N/A |
Primer for the preparation of RBD L452R expression plasmid (RBD L452R):GGA CAG CAA GGT GGG AGG CAA CTA CAA CTA CAG ATA CAG ACT GTT CAG GAA GAG CAA C | This study | N/A |
Primer for the preparation of RBD Y453F expression plasmid (RBD Y453F): CTC AAA TGG TTT CAG GTT GCT CTT CCT GAA CAG TCT GAA GAG GTA GTT GTA GTT GCC TCC C | This study | N/A |
Primer for the preparation of RBD N501Y expression plasmid (RBD N501Y): GTA TGG TTG GTA GCC CAC TCC ATA GGT TGG TTG GAA GCC ATA GGA TTG | This study | N/A |
Primer for the preparation of the RBD expression plasmid CAT GGG AAA ACA TGT TGT TTA CGG AG | This study | N/A |
Primer for the preparation of the RBD expression plasmid preparation: GCA GCC CCA TAA ACA CAC AGT AT | This study | N/A |
Forward primer for the preparation of Fragment 8, S L452R: CTA AGG TTG GTG GTA ATT ATA ATT ACC GGT ATA GAT TGT TTA GGA AGT CTA ATC | This study | N/A |
Reverse primer for the preparation of Fragment 8, S L452R: GAT TAG ACT TCC TAA ACA ATC TAT ACC GGT AAT TAT AAT TAC CAC CAA CCT TAG | This study | N/A |
Forward primer for the preparation of Fragment 8, S Y453F: GGT TGG TGG TAA TTA TAA TTA CCT GTT TAG ATT GTT TAG GAA GTC TAA TCT C | This study | N/A |
Reverse primer for the preparation of Fragment 8, S Y453F: GAG ATT AGA CTT CCT AAA CAA TCT AAA CAG GTA ATT ATA ATT ACC ACC AAC C | This study | N/A |
Forward primer for the preparation of Fragment 8, S N501Y: CAA TCA TAT GGT TTC CAA CCC ACT TAT GGT GTT GGT TAC CAA CCA TAC AG | This study | N/A |
Reverse primer for the preparation of Fragment 8, S N501Y: CTG TAT GGT TGG TAA CCA ACA CCA TAA GTG GGT TGG AAA CCA TAT GAT TG | This study | N/A |
SARS-CoV-2 S forward primer for the mutation verification (WK-521, 22607-22630 forward): GCA TCT GTT TAT GCT TGG AAC AGG | Torii et al., 2021 | N/A |
SARS-CoV-2 S reverse primer for the mutation verification (WK-521, 23342-23367 reverse): CCT GGT GTT ATA ACA CTG ACA CCA CC | Torii et al., 2021 | N/A |
SARS-CoV-2 N forward primer for real-time RT-PCR: AGC CTC TTC TCG TTC CTC ATC AC | This study | N/A |
SARS-CoV-2 N reverse primer for real-time RT-PCR: CCG CCA TTG CCA GCC ATT C | This study | N/A |
Forward primer for competition assay: CAG GGC AAA CTG GAA AGA TT | This study | N/A |
Reverse primer for competition assay: TCA GCA ATG TCT CTG CCA AA | This study | N/A |
Sequencing primer for competition assay: CAG GGC AAA CTG GAA AGA TT | This study | N/A |
Random hexamer | Sigma-Aldrich | N/A |
Recombinant DNA | ||
Plasmid: pC-SARS2-S | Ozono et al., 2021 | N/A |
Plasmid: pCAGGS | Niwa et al., 1991 | N/A |
Plasmid: pC-SARS2-S-L452R | This study | N/A |
Plasmid: pC-SARS2-S-Y453F | This study | N/A |
Plasmid: pC-SARS2-S-N501Y | This study | N/A |
Plasmid: pC-SARS2-S-D614G | Ozono et al., 2021 | N/A |
Plasmid: pC-SARS2-S-B.1.429 [S13I/W152C/L452R/D614G] | This study | N/A |
Plasmid: pC-SARS2-S-B.1.1.298 [HV69-70del/Y453F/D614G] | This study | N/A |
Plasmid: pTargeT-human ACE2 | Fukushi et al., 2007 | N/A |
Plasmid: pLV-EF1a-IRES-Puro | Addgene | Cat# #85132 |
Plasmid: pLV-EF1a-human ACE2-IRES-Puro | This study | N/A |
Plasmid: pC-ACE2 | Ozono et al., 2021 | N/A |
Plasmid: pC-mink ACE2 | This study | N/A |
Plasmid: pHL-sec | Addgene | Cat# 99845 |
Plasmid: pHL-sec-human ACE2 (residues 18-740) | Zahradník et al., 2021a | N/A |
Plasmid: pJYDC1 | Addgene | Cat# 162458 |
Plasmid: pJYDC1-SARS-CoV-2 S RBD (residues 336-528) | Zahradník et al., 2021a | N/A |
Plasmid: pJYDC1-SARS-CoV-2 S RBD L452R | This study | N/A |
Plasmid: pJYDC1-SARS-CoV-2 S RBD Y453F | This study | N/A |
Plasmid: pJYDC1-SARS-CoV-2 S RBD N501Y | This study | N/A |
Plasmid: psPAX2-IN/HiBiT | Ozono et al., 2020 | N/A |
Plasmid: pWPI-Luc2 | Ozono et al., 2020 | N/A |
Plasmid: pC-TMPRSS2 | Ozono et al., 2021 | N/A |
Plasmid: pΔ-NRF | Naldini et al., 1996 | N/A |
Plasmid: pVSV-G | Addgene | Cat# 138479 |
Plasmid: template plasmids for the preparation of the partial SARS-CoV-2 genome fragments for CPER, see Table S6 | Torii et al., 2021 | N/A |
Plasmid: pDSP1-7 | Kondo et al., 2011 | N/A |
Plasmid: pDSP8-11 | Kondo et al., 2011 | N/A |
Software and algorithms | ||
NetMHCpan (v 4.1) |
Reynisson et al., 2020; Katoh and Standley, 2013 |
http://www.cbs.dtu.dk/services/NetMHCpan/ |
NetMHC (v 4.0) | Andreatta and Nielsen, 2016; Lundegaard et al., 2008; Nielsen et al., 2003 | http://www.cbs.dtu.dk/services/NetMHC/ |
SMM tool | Andreatta and Nielsen, 2016 | http://tools.iedb.org/mhci/help/ |
PickPocket (v 1.1) | Zhang et al., 2009 | http://www.cbs.dtu.dk/services/PickPocket/ |
NetMHCcons (v 1.1) | Karosiene et al., 2012 | http://www.cbs.dtu.dk/services/NetMHCcons/ |
MAFFT suite (v7.467) | Katoh and Standley, 2013 | https://mafft.cbrc.jp/alignment/software/ |
ModelTest-NG (v0.1.5) | Darriba et al., 2020 | https://github.com/ddarriba/modeltest |
RAxML-NG (v1.0.0) | (Kozlov et al., 2019) | https://github.com/amkozlov/raxml-ng |
FigTree (v1.4.4) | Andrew Rambaut | http://tree.bio.ed.ac.uk/software/figtree |
trimAl (v1.4.rev22) | Capella-Gutiérrez et al., 2009 | http://trimal.cgenomics.org |
Python (v3.7) | Python Software Foundation | https://www.python.org |
Sequencher (v5.1) | Gene Codes Corporation | N/A |
PyMOL (v2.3.0) | Schrödinger | https://pymol.org/2/ |
UCSF Chimera (v1.13) | Pettersen et al., 2004 | N/A |
Prism | GraphPad Software | https://www.graphpad.com/scientific-software/prism/ |
Tracy | Rausch et al., 2020 | https://www.gear-genomics.com/teal/ |
EditR | Kluesner et al., 2018 | http://baseeditr.com |
Other | ||
GISAID | Freunde von GISAID e.V. | https://www.gisaid.org |
Pangolin | Rambaut et al., 2020 | https://cov-lineages.org/pangolin.html |
0.45-μm pore size filter | Thermo Fisher Scientific | Cat# 09-740-114 |
40-μm cell strainer | SPL Life Sciences | Cat# 93040 |
HisTrap Fast Flow column | Cytiva | Cat# 17-5255-01 |
Ultracel-3 regenerated cellulose membrane | Merck | Cat# UFC900324 |
0.45-μm pore size filter | Merck | Cat# SLGVR33RB |
96-well black plate | PerkinElmer | Cat# 6005225 |